Key facts
- This page summarizes Elliot Zemel's Form 3 filing for CANNAPHARMARX, INC. (CPMD).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 10 Apr 2025, 21:42.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Under the terms of the LTB transaction with the Issuer, Koze Investments LLC was issued: (i) 1,3612,481 warrants entitling the holder to purchase one share of common stock of the Company at $0.02 per share until November 22, 2028; (ii) $2,550,000 in promissory notes payable to Koze Investments (iii) $68,555.43 in convertible notes at an exercise price of the lowest 60 day share price before the period end; and (iv) 100,000 Class C preferred shares each convertible into 1,250 shares of common stock. Mr. Zemel is not permitted to, at any time, to own more than 4.99% of the outstanding shares of common stock of the Company.